Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Brian D. Graner"'
Autor:
Michael C. Veronesi, Brian D. Graner, Shih-Hsun Cheng, Marta Zamora, Hamideh Zarrinmayeh, Chin-Tu Chen, Sudip K. Das, Michael W. Vannier
Publikováno v:
Pharmaceutics, Vol 13, Iss 3, p 391 (2021)
The fate of intranasal aerosolized radiolabeled polymeric micellar nanoparticles (LPNPs) was tracked with positron emission tomography/computer tomography (PET/CT) imaging in a rat model to measure nose-to-brain delivery. A quantitative temporal and
Externí odkaz:
https://doaj.org/article/28f03d1b4f9441d0b24845d494dfa386
Publikováno v:
Journal of Neuroimaging. 32:565-581
The tauopathies are a heterogeneous group of neurodegenerative disorders in which the prevailing underlying disease process is intracellular deposition of abnormal misfolded tau protein. Diseases often categorized as tauopathies include progressive s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::656b9129da92535304cc0b704f52aebe
https://doi.org/10.1111/jon.13001
https://doi.org/10.1111/jon.13001
Autor:
Chin-Tu Chen, Michael W. Vannier, Marta Zamora, Sudip Kumar Das, Shih-Hsun Cheng, Hamideh Zarrinmayeh, Michael C. Veronesi, Brian D Graner
Publikováno v:
Pharmaceutics
Pharmaceutics, Vol 13, Iss 391, p 391 (2021)
Volume 13
Issue 3
Pharmaceutics, Vol 13, Iss 391, p 391 (2021)
Volume 13
Issue 3
The fate of intranasal aerosolized radiolabeled polymeric micellar nanoparticles (LPNPs) was tracked with positron emission tomography/computer tomography (PET/CT) imaging in a rat model to measure nose-to-brain delivery. A quantitative temporal and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::23840f107884b996385a62598006a417
https://doi.org/10.3390/pharmaceutics13030391
https://doi.org/10.3390/pharmaceutics13030391
Autor:
James M. Kofler, Steve G. Langer, Beth A. Schueler, Kenneth A. Fetterly, Jayawant N. Mandrekar, Brian J. Bartholmai, Brian D. Graner
Publikováno v:
Journal of digital imaging. 29(1)
Thoracic computed tomography (CT) is considered the gold standard for detection lung pathology, yet its efficacy as a screening tool in regards to cost and radiation dose continues to evolve. Chest radiography (CXR) remains a useful and ubiquitous to
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::03da70de62e9bcc8bfd1aac293e8067e
https://pubmed.ncbi.nlm.nih.gov/26349914
https://pubmed.ncbi.nlm.nih.gov/26349914